S C Kogan

Summary

Affiliation: University of Central Florida
Country: USA

Publications

  1. ncbi The PEBP2betaMYH11 fusion created by Inv(16)(p13;q22) in myeloid leukemia impairs neutrophil maturation and contributes to granulocytic dysplasia
    S C Kogan
    G W Hooper Foundation, University of California, San Francisco, CA 94143 0552, USA
    Proc Natl Acad Sci U S A 95:11863-8. 1998
  2. ncbi BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRARalpha) to block neutrophil differentiation and initiate acute leukemia
    S C Kogan
    Department of Laboratory Medicine, University of California at San Francisco, San Francisco, California 94143, USA
    J Exp Med 193:531-43. 2001
  3. ncbi Acute promyelocytic leukemia: a view from a mouse
    S C Kogan
    Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA 94143 0128, USA
    Blood Cells Mol Dis 26:620-5. 2000
  4. ncbi Mouse models of acute promyelocytic leukemia
    S C Kogan
    Department of Laboratory Medicine and Comprehensive Cancer Center, University of California, San Francisco, Room S 864, 513 Parnassus Avenue, San Francisco, CA 94143 0100, USA
    Curr Top Microbiol Immunol 313:3-29. 2007

Collaborators

Detail Information

Publications4

  1. ncbi The PEBP2betaMYH11 fusion created by Inv(16)(p13;q22) in myeloid leukemia impairs neutrophil maturation and contributes to granulocytic dysplasia
    S C Kogan
    G W Hooper Foundation, University of California, San Francisco, CA 94143 0552, USA
    Proc Natl Acad Sci U S A 95:11863-8. 1998
    ..These results show that PEBP2betaMYH11 can impair neutrophil development and provide evidence that alterations of Pebp2 can contribute to the genesis of myelodysplasia...
  2. ncbi BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRARalpha) to block neutrophil differentiation and initiate acute leukemia
    S C Kogan
    Department of Laboratory Medicine, University of California at San Francisco, San Francisco, California 94143, USA
    J Exp Med 193:531-43. 2001
    ..Our results indicate that genetic changes that inhibit apoptosis can cooperate with PMLRARalpha to initiate APL...
  3. ncbi Acute promyelocytic leukemia: a view from a mouse
    S C Kogan
    Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA 94143 0128, USA
    Blood Cells Mol Dis 26:620-5. 2000
    ..Molecularly targeted therapies that either restore maturation or abrogate growth autonomy represent a hope for improving survival of patients with other subtypes of AML...
  4. ncbi Mouse models of acute promyelocytic leukemia
    S C Kogan
    Department of Laboratory Medicine and Comprehensive Cancer Center, University of California, San Francisco, Room S 864, 513 Parnassus Avenue, San Francisco, CA 94143 0100, USA
    Curr Top Microbiol Immunol 313:3-29. 2007
    ..Furthermore, preclinical studies utilizing these mice have advanced therapy for myeloid leukemia...